BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37431554)

  • 21. Clinical risk score for invasive fungal diseases in patients with hematological malignancies undergoing chemotherapy: China Assessment of Antifungal Therapy in Hematological Diseases (CAESAR) study.
    Wang L; Wang Y; Hu J; Sun Y; Huang H; Chen J; Li J; Ma J; Li J; Liang Y; Wang J; Li Y; Yu K; Hu J; Jin J; Wang C; Wu D; Xiao Y; Huang X
    Front Med; 2019 Jun; 13(3):365-377. PubMed ID: 30604166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiation Dose Reduction by Using CT with Iterative Model Reconstruction in Patients with Pulmonary Invasive Fungal Infection.
    Yan C; Xu J; Liang C; Wei Q; Wu Y; Xiong W; Zheng H; Xu Y
    Radiology; 2018 Jul; 288(1):285-292. PubMed ID: 29634436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fungal biomarker monitoring and CT scans for early detection of invasive fungal disease in neutropenic hematological patients.
    Kimura SI; Kanda Y; Oyake T; Yamaguchi H; Fujiwara SI; Okamoto A; Fujita H; Saburi Y; Tamura K;
    J Infect; 2022 Jan; 84(1):80-86. PubMed ID: 34710391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiologic findings of Fusarium pneumonia in neutropenic patients.
    Sassi C; Stanzani M; Lewis RE; Vianelli N; Tarsi A; Poerio A; Cavo M; Battista G
    Mycoses; 2017 Feb; 60(2):73-78. PubMed ID: 27470138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can magnetic resonance imaging be an alternative to computed tomography in immunocompromised patients with suspected fungal infections? Feasibility of a speed optimized examination protocol at 3 Tesla.
    Nagel SN; Wyschkon S; Schwartz S; Hamm B; Elgeti T
    Eur J Radiol; 2016 Apr; 85(4):857-63. PubMed ID: 26971435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multi-detector computed tomography angiography for coronary artery disease: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(5):1-57. PubMed ID: 23074474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Applicability of the EORTC/MSG criteria for IFD in clinical practice.
    Rieger H; Lustig D; Barlow S; Ostermann H; Fiegl M; Peterson L; Rieger CT
    Ann Hematol; 2015 May; 94(5):847-55. PubMed ID: 25544029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The value of the chest computed tomography halo sign in the diagnosis of invasive pulmonary aspergillosis. An autopsy-based retrospective study of 48 patients.
    Kami M; Kishi Y; Hamaki T; Kawabata M; Kashima T; Masumoto T; Oki Y; Tanaka Y; Sawada S; Machida U; Ohtomo K; Kanda Y; Hirai H; Mutou Y
    Mycoses; 2002 Oct; 45(8):287-94. PubMed ID: 12572717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical risk score for predicting invasive fungal disease after allogeneic hematopoietic stem cell transplantation: Analysis of the China Assessment of Antifungal Therapy in Hematological Diseases (CAESAR) study.
    Sun Y; Hu J; Huang H; Chen J; Li J; Ma J; Li J; Liang Y; Wang J; Li Y; Yu K; Hu J; Jin J; Wang C; Wu D; Xiao Y; Huang X
    Transpl Infect Dis; 2021 Aug; 23(4):e13611. PubMed ID: 33825274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in the epidemiology of invasive fungal disease in a Pediatric Hematology and Oncology Unit: the relevance of breakthrough infections.
    Calle-Miguel L; Garrido-Colino C; Santiago-García B; Moreno Santos MP; Gonzalo Pascual H; Ponce Salas B; Beléndez Bieler C; Navarro Gómez M; Guinea Ortega J; Rincón-López EM
    BMC Infect Dis; 2023 May; 23(1):348. PubMed ID: 37226103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imaging of pulmonary fusariosis in patients with hematologic malignancies.
    Marom EM; Holmes AM; Bruzzi JF; Truong MT; O'Sullivan PJ; Kontoyiannis DP
    AJR Am J Roentgenol; 2008 Jun; 190(6):1605-9. PubMed ID: 18492913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current Algorithms in Fungal Diagnosis in the Immunocompromised Host.
    Lehrnbecher T; Becker K; Groll AH
    Methods Mol Biol; 2017; 1508():67-84. PubMed ID: 27837498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Introducing 1,3-beta-d-glucan for screening and diagnosis of invasive fungal diseases in Australian high-risk haematology patients: is there a clinical benefit?
    Garnham K; Halliday CL; Rai NJ; Jayawardena M; Hasan T; Kok J; Nayyar V; Gottlieb DJ; Gilroy NM; Chen SC
    Intern Med J; 2022 Mar; 52(3):426-435. PubMed ID: 32896984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and validation of a risk model for identification of non-neutropenic, critically ill adult patients at high risk of invasive Candida infection: the Fungal Infection Risk Evaluation (FIRE) Study.
    Harrison D; Muskett H; Harvey S; Grieve R; Shahin J; Patel K; Sadique Z; Allen E; Dybowski R; Jit M; Edgeworth J; Kibbler C; Barnes R; Soni N; Rowan K
    Health Technol Assess; 2013 Feb; 17(3):1-156. PubMed ID: 23369845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosis of invasive fungal diseases in haematology and oncology: 2018 update of the recommendations of the infectious diseases working party of the German society for hematology and medical oncology (AGIHO).
    Ruhnke M; Behre G; Buchheidt D; Christopeit M; Hamprecht A; Heinz W; Heussel CP; Horger M; Kurzai O; Karthaus M; Löffler J; Maschmeyer G; Penack O; Rieger C; Rickerts V; Ritter J; Schmidt-Hieber M; Schuelper N; Schwartz S; Ullmann A; Vehreschild JJ; von Lilienfeld-Toal M; Weber T; Wolf HH
    Mycoses; 2018 Nov; 61(11):796-813. PubMed ID: 30098069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abass Alavi: A giant in Nuclear Medicine turns 80 and is still going strong!
    Høilund-Carlsen PF
    Hell J Nucl Med; 2018; 21(1):85-87. PubMed ID: 29550853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Galactomannan in bronchoalveolar lavage for diagnosing invasive fungal disease.
    Affolter K; Tamm M; Jahn K; Halter J; Passweg J; Hirsch HH; Stolz D
    Am J Respir Crit Care Med; 2014 Aug; 190(3):309-17. PubMed ID: 25007380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detecting Pulmonary Nodules in Lung Cancer Patients Using Whole Body FDG PET/CT, High-resolution Lung Reformat of FDG PET/CT, or Diagnostic Breath Hold Chest CT.
    Flavell RR; Behr SC; Mabray MC; Hernandez-Pampaloni M; Naeger DM
    Acad Radiol; 2016 Sep; 23(9):1123-9. PubMed ID: 27283073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Positron Emission Tomography Computed Tomography: A Guide for the General Radiologist.
    Beadsmoore C; Newman D; MacIver D; Pawaroo D
    Can Assoc Radiol J; 2015 Nov; 66(4):332-47. PubMed ID: 26277234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aspergillus-PCR in bronchoalveolar lavage for detection of invasive pulmonary aspergillosis in immunocompromised patients.
    Buess M; Cathomas G; Halter J; Junker L; Grendelmeier P; Tamm M; Stolz D
    BMC Infect Dis; 2012 Oct; 12():237. PubMed ID: 23031334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.